GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lupin Ltd (NSE:LUPIN) » Definitions » YoY EPS Growth

Lupin (NSE:LUPIN) YoY EPS Growth : 52.13% (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Lupin YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Lupin's YoY EPS Growth for the quarter that ended in Mar. 2024 was 52.13%.

Lupin's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was ₹7.85.

Lupin YoY EPS Growth Historical Data

The historical data trend for Lupin's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lupin YoY EPS Growth Chart

Lupin Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -144.54 549.08 -225.94 127.96 344.95

Lupin Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 145.26 605.10 276.14 299.11 52.13

Lupin YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Lupin's YoY EPS Growth for the fiscal year that ended in Mar. 2024 is calculated as:

YoY EPS Growth (A: Mar. 2024 )
=(Earnings per Share (Diluted) (A: Mar. 2024 )-Earnings per Share (Diluted) (A: Mar. 2023 ))/ | Earnings per Share (Diluted) (A: Mar. 2023 ) |
=(41.87-9.41)/ | 9.41 |
=344.95 %

Lupin's YoY EPS Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EPS Growth (Q: Mar. 2024 )
=(Earnings per Share (Diluted) (Q: Mar. 2024 )-Earnings per Share (Diluted) (Q: Mar. 2023 )) / | Earnings per Share (Diluted) (Q: Mar. 2023 )) |
=(7.85-5.16)/ | 5.16 |
=52.13 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lupin YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Lupin's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Lupin (NSE:LUPIN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lupin Ltd (NSE:LUPIN) » Definitions » YoY EPS Growth
Comparable Companies
NSE:AUROPHARMA BOM:532321 NSE:ALKEM NSE:TORNTPHARM BOM:543904 BOM:524494 BOM:532331 BOM:506943 BOM:532296 BOM:540222 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
500257:India
Address
Off. Western Express Highway, 3rd floor, Kalpataru Inspire, Santacruz (East), Mumbai, MH, IND, 400 055
Website
https://www.lupin.com
Lupin Ltd is a specialty and generic drug manufacturing company. The company's global formulations business develops and delivers a wide range of branded and generic formulations across the globe. The operations of the company are limited to one segment, namely pharmaceuticals and related products. The company also maintains a pipeline in high-barrier markets such as Inhalation, Biosimilars and Complex Injectables. The vast majority of the company's sales are generated in the United States, followed by India.

Lupin (NSE:LUPIN) Headlines

No Headlines